Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Synthetic double-stranded siRNA oligonucleotide directed against claudin-5 complexed with polyethyleneimine (prior to administration of doxorubicin)

EU orphan designation number: EU/3/12/1065   
Active ingredient: Synthetic double-stranded siRNA oligonucleotide directed against claudin-5 complexed with polyethyleneimine (prior to administration of doxorubicin)
Indication: Treatment of glioma
Sponsor: Avena Therapeutics Ltd
Trinity Research and Innovation, Trinity College Dublin, Dublin 2, Ireland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/11/2012 Centralised Orphan - Designation EMA/OD/136/12 (2012)8198 of 08/11/2012